Table 2.

Concomitant medications.

MedicationBefore Study, Patients, n (%)During Study, Patients, n (%)
CCB22 (56.4)7 (17.9)
Antiplatelet agents12 (30.7)12 (30.7)
ACEI/ARB10 (25.64)8 (20.5)
ERT9 (23)9 (23)
SSRI6 (15.4)0
Glucocorticoids6 (15.4)4 (10.2)
Statins4 (10.2)4 (10.2)
  • CCB: calcium channel blockers; ACEI: angiotensin converting enzyme inhibitor; ARB: angiotensin receptor blocker; ERT: estrogen replacement therapy; SSRI: selective serotonin reuptake inhibitor.